CAS number: 3385-03-03

General information about the Flunisolide Anhydrous active pharmaceutical ingredient

Flunisolide Anhydrous as active pharmaceutical ingredient (API) is a corticosteroid or steroid, class of glucocorticoid used for the treatment of asthma and allergic rhinitis. Flunisolide Anhydrous API works by reducing swelling in the nasal passages. Flunisolide Anhydrous can be administered as an oral metered-dose inhaler for the treatment of asthma or as a nasal spray for treating allergic rhinitis.

Axplora manufactures Flunisolide Anhydrous API

Flunisolide Anhydrous API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Flunisolide Anhydrous API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Flunisolide Anhydrous API is commercially available as micronized grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Flunisolide Anhydrous API.
  • Therapeutic area Anti-Asthmatic
  • Monograph USP
  • Available grade Micronized
  • Regulatory documentation EU DMF
    US DMF#
  • Produced in GRO